packing for PPH had been in use previously for decades but due to fear of infection and concealed haemorrhage its use subsequently declined.
In addition, vaginal vault prolapse or uterovaginal
prolapse could be present.
At approximately 13 weeks, these two solid evaginations grow out of the pelvic part of the urogenital sinus and proliferate into the caudal end of the uterovaginal
canal to become a solid vaginal plate.
Age as risk factors associated in the genesis of uterovaginal
Suspension of the vagina to the presacral region is an effective treatment for uterovaginal
prolapse. The abdominal approach was considered if the patient had uterine or ovarian pathology that needs to manage with hysterectomy or adnexectomy and also have anterior vaginal defect or urinary incontinence that needs to perform paravaginal defect repair or Burch colposuspension. Total recurrence rate was 13.7% with transvaginal approach. Moreover, the recurrence rate was 5% by abdominal approach. About 92% of success rate by the robotic surgery that there was no significant difference with vaginal approach. Robotic surgery could be done with uterosacral suspension concomitant total or subtotal hysterectomy.
Histological and histochemical studies on the oviduct of the domestic fowl with special reference to the region of uterovaginal
The anatomical structures associated with prolonged sperm storage are the infundibulum and the uterovaginal
junction (UVJ), and the latter is the primary sperm storage tubules (SSTs) (Bakst, 2011).
The ligament supporting the uterus gets weakened, and hence the chances of uterovaginal
prolapse increases," she added.
Trends in hysteropexy and apical support for uterovaginal
prolapse in the United States from 2002 to 2012.
The effect of uterovaginal
prolapse on urethrovesical pressure dynamics.
Patients were excluded from the study if they had undergone previous cervical cone biopsy or surgery requiring cervical tissue removal; cervical incompetence; a history of cervical laceration repair during vaginal birth; cervical stenosis; contraindications for the use of misoprostol (history of severe asthma, glaucoma, pre-existing cardiac disease, hypertension, or renal failure); or significant uterovaginal
prolapse precluding the administration of vaginal tablets.
(a) Urogenital sinus (UGS) at about 12 weeks: (1) genital tubercle, (2) vestibule, (2a) urogenital sinus (UGS) phallic portion, (2b) UGS pelvic portion, (3) vaginal epithelial blade, (4) perineum, (5) rectum, (6) uterovaginal
canal, (7) bladder, and (8) urethra.